2 Followers on Owler

Genespire

develops and commercializes gene therapies for the treatment of immunodeficiency disorders and inherited metabolic diseases... Read more
OverviewCompetitorsFundingNews & Insights

Genespire

develops and commercializes gene therapies for the treatment of immunodeficiency disorders and inherited metabolic diseases... Read more
Genespire CEO: Karen Aiach-Pignet

CEO

Karen Aiach-Pignet

CEO Approval Rating

- -/100

2020

PrivateIndependent Company

Pharmaceuticals & Biotechnology
Biotechnology

Est. Annual Revenue
$100K-5.0M
Agree?
Est. Employees
1-25
Agree?
Funding
$69.3M

News

Funding
Sep 25, 2024
FinanzNachrichten
Genespire received $52M in Series B Funding
Leadership Change
Sep 12, 2024
GlobalNewswire
Karen Aiach-Pignet joined Genespire as CEO

Genespire Competitors

1Alize Pharma
2Asceneuron
3Doc Generici
4Brunifarma
5Denali
6CHEMI
7Friulchem
8Spark Therapeutics
9Adocia
10Pharmascience
Unlock 15 + competitors

Trending Companies